Eine empirische Studie. Raven, New York, pp 207–222, Rey E-R, Jahn T, Grundmann J, Platz M (1995) Zur Gültigkeit des »Crossover-Effektes« in Reaktionszeituntersuchungen schizophrener Patienten. Schizophr Bull 26: 193–200, Sobizack N, Albus M, Hubmann W, Mohr F, Binder J, Hecht S, Scherer J (1999) Neuropsychologische Defizite bei ersterkrankten schizophrenen Patienten. Psychiatry Res 53: 119–127, Green MF, Satz P, Christenson C (1994b) Minor physical anomalies in schizophrenia patients, bipolar patients, and their siblings. Arch Gen Psychiatry 55: 145–152, Gurling HM, Kalsi G, Brynjolfson J et al (2001) Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21–22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3–24 and 20q12.1–11.23. Sie sind Psychotherapeut? Am J Hum Genet 73: 152–161, Breier A, Su TP, Saunders R et al (1997) Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography methods. Neurocase 9: 274–282, Nelson HE (1976) A modified card sorting test sensitive to frontal lobe defects. Schizophr Res 6: 25–30, Schumacher J, Jamra RA, Freudenberg J et al (2004) Examination of G72 and D-amino acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Arch Gen Psychiatry 55: 433–440, Ngan ET, Yatham LN, Ruth TJ, Liddle PF (2000) Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia: a PET study using [(18)F]setoperone. Gerhard Roth, © 2006 Springer Medizin Verlag Heidelberg, Jahn, T., Rockstroh, B. Fortschr Neurol Psychiatr 69: 105–115, Schröder J (1997) Subsyndrome der chronischen Schizophrenie. Onderzoekingen Gedaan in het Physiologisch Laboratorium der Utrechtsche Hoogeschool. Vision Res 40: 1301–1310, Kraepelin E (1904) Psychiatrie. Hogrefe, Göttingen, S 435–454, Jahn T, Cohen R, Hubmann W et al (2005a) The Brief Motor Scale (BMS) for the assessment of motor signs in schizophrenic psychoses and other psychiatric disorders. Br J Psychiatry 158: 529–533, an der Heiden W, Hafner H (2000) The epidemiology of onset and course of schizophrenia. Biol Psychiatry 46: 908–920, Arduini L, Kalyvoka A, Stratta P, Rinaldi O, Daneluzzo E, Rossi A (2003) Insight and neuropsychological function in patients with schizophrenia and bipolar disorder with psychotic features. Biol Psychiatry 45: 1–16, Furlong P, Barczak P, Hayes G, Harding G (1990) Somatosensory evoked potentials in schizophrenia. Biol Psychiatry 53: 1099–1112, Raine A, Lencz T, Yaralian P, Bihrle S, LaCasse L, Ventura J, Colletti P (2002) Prefrontal structural and functional deficits in schizotypal personality disorder. Schizophr Bull 27: 269–279, Bilder RM, Goldman RS, Robinson D et al (2000) Neuropsychology of first-episode schizophrenia: Initial characterization and clinical correlates. Schizophr Res 58: 159–172, Tiihonen J, Hari R, Naukkarinen H, Rimon R, Jousmaki V, Kajola M (1992) Modified activity of the human auditory cortex during auditory hallucinations. Mol Psychiatry 7: 822–826, Azmitia EC (2001) Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation, and apoptosis. Google Scholar, Costa E, Grayson DR, Mitchell CP, Tremolizzo L, Veldic M, Guidotti A (2003) GABAergic cortical neuron chromatin as a putative target to treat schizophrenia vulnerability. Psychol Med 31: 1065–1078, Straube ER, Oades RD (1992) Schizophrenia: Empirical research and findings. Steinkopff, Darmstadt, pp 141–162, Jones HM, Pilowsky (2002) Dopamine and antipsychotic drug action revisited. Toward a unitary pathogenetic mechanism. Psychiatry Clin Neurosci 55: 347–352, Youn T, Park HJ, Kim JJ, Kwon JS (2003) Altered hemispheric asymmetry and positive symptoms in schizophrenia: equivalent current dipole of auditory mismatch negativity. Am J Hum Genet 72: 185–190, Schwarcz R, Rassoulpour A, Wu HQ et al (2001) Increased cortical kynureninate content in schizophrenia. Psychiatry Res 115: 15–35, Shergill SS, Brammer MJ, Williams SC, Murray RM, McGuire PK (2000) Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging. Br J Psychiatry 183: 414–417, Ho BC, Andreasen NC, Flaum M, Nopoulos P, Miller D (2000) Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia. Am J Hum Genet 71: 337–348, Suslow T, Arolt V (1998) Backward masking in schizophrenia: time course of visual processing deficits during task performance. J Nerv Ment Dis 187: 525–531, Mohamed S, Paulsen JS, O’Leary D, Arndt S, Andreasen N (1999b) Generalized cognitive deficits in schizophrenia. Schizophrenie ist eine psychische Störung, die meist in der späten Pubertät oder dem frühen Erwachsenenalter auftritt, aber in jedem Lebensalter ausbrechen kann. WebUm eine Schizophrenie diagnostizieren zu können, müssen die Symptome laut Dr. Geisler mindestens sechs Monate lang kontinuierlich vorhanden sein. Am J Psychiatry 156: 1358–1366, CAS  Deuticke, Leipzig, Blouin JL, Dombroski BA, Nath SK et al (1998) Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nature 391: 756, Braff DL, Saccuzzo DP(1981) Information processing dysfunction in paranoid schizophrenia: a two-factor deficit. Schizophr Res 60: 141–155, Davidson LL, Heinrichs RW (2003) Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: a meta-analysis. Biol Psychiatry 53: 412–421, Bedwell JS, Brown JM, Miller LS (2003) The magnocellular visual system and schizophrenia: what can the color red tell us? Google Scholar, Green MF, Kern RS, Braff DL, Mintz J (2000) Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the »right stuff«? Schizophr Bull 27: 687–695, Wilke I, Arolt V, Rothermundt M, Weitzsch C, Hornberg M, Kirchner H (1996) Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients. Nature Genet 11: 287–293, Straub RE, MacLean CJ, O’Neill FA, Walsh D, Kendler KS (1997) Support for a possible schizophrenia vulnerability locus in region 5q22-31 in Irish families. J Biosci 27: 35–52, Pulver AE, Lasseter VK, Kasch L et al (1995) Schizophrenia: a genome scan targets chromosomes 3p and 8p as potential sites of susceptibility genes. Br J Psychiatry 157: 735–739, Rothermundt M, Arolt V, Weitzsch C, Eckhoff D, Kirchner H (1996) Production of cytokines in acute schizophrenic psychosis. setzt sich seit 2004 für eine bessere Versorgung von Menschen mit psychischen Problemen und ihren Angehörigen ein. Audiol Neuro-Otol 3: 183–190, Pascual-Marqui R, Lehmann D, König T, Kochi K, Merlo MC, Hell D, Koukkou M (1999) Low resolution brain electromagnetic tomography (LORETA) functional imaging in acute, neuroleptic-naive, first-episode, productive schizophrenia. Nature Genet 20: 70–73, Boin F, Zanardini R, Pioli R, Altamura CA, Maes M, Gennarelli M (2001) Association between G308A tumor necrosis factor alpha gene polymorphism and schizophrenia. Br J Psychiatry Suppl 43: 50–57, Dazzan P, Morgan KD, Orr KG et al (2004) The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Curr Opin Psychiatry 16: 149–155, Hoff AL, Sakuma M, Wieneke M, Horon R, Kushner M, DeLisi LE (1999) Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia. Biol Psychiatry 45: 17–25, Selemon LD, Rajkowska G (2003) Cellular pathology in the dorsolateral prefrontal cortex distinguishes schizophrenia from bipolar disorder. Biol Psychiatry 12: 221–235, Shapleske J, Rossell SL, Woodruff PW, David AS (1999) The planum temporale: a systematic, quantitative review of its structural, functional and clinical significance. Schizophr Res 62: 59–64, CrossRef  Springer, Berlin Heidelberg New York, S 39–70, Munk-Jörgensen P, Ewald H (2001) Epidemiology in neurobiological research: exemplified by the influenza-schizophrenia theory. Am J Hum Genet 65: 1114–1124, Hulshoff Pol HE, Schnack HG, Mandl RC, Cahn W, Collins DL, Evans AC, Kahn RS (2004) Focal white matter density changes in schizophrenia: reduced inter-hemispheric connectivity. Manische Zustände führen oft zu einem geringeren Schlafbedürfnis und zu einer geringeren Flüssigkeits- und Nahrungsaufnahme – Faktoren, die bei älteren Menschen schnell zu schweren körperlichen Störungen führen können. Psychophysiology 36: 667–682, Ford JM, White PM, Csermansky JG, Faustman WO, Roth WT, Pfefferbium A (1994) ERPs in schizophrenia: effects of antipsychotic medication. Psychiatry Res 15: 69–87, Dazzan P, Murray RM (2002) Neurological soft signs in first-episode psychosis: a systematic review. In: Johnson R, Rohrbaugh JW, Parasuraman R (eds) Current trends in event-related potential research (EEG Suppl 40). Schizophr Bull 26: 119–136, Grove WM, Lebow BS, Clementz BA, Cerri A, Medus C, Iacono WG (1991) Familial prevalence and coaggregation of schizotypy indicators: a multitrait family study. J Psychiatry Res 34: 45–56, Jahn T (1999) Diskrete motorische Störungen bei Schizophrenie. Psychiatry Res 64:105–114, Lane A, Kinsella A, Murphy P et al (1997) The anthropometric assessment of dysmorphic features in schizophrenia as an index of its developmental origins. CAS  Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. © 2023 Springer Nature Switzerland AG. A twin study of neurological soft signs. Blackwell, Malden, pp 326–348, Weinberger DR, Berman KF, Zec RF (1986) Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia: 1. PubMed Central  Die Symptome einer Schizophrenie können je nach Erkrankungsform … Acta Psychiatr Scand Suppl 396: 68–79, Frith CD (1992) The cognitive neuropsychology of schizophrenia. Biol Psychiatry 32: 595–606, Elbert T, Junghöfer M, Rockstroh B, Roth WT (2001) Psychophysiologische Grundlagen und Meßmethoden der Hirnaktivität. The Feinberg hypothesis revisited. pp 589–599, Konick LC, Friedman L (2001) Meta-analysis of thalamic size in schizophrenia. Biol Psychiatry 45: 107–115, McCarley RW, Niznikiewics MA, Salisbury DF et al (1999) Cognitive dysfunction in schizophrenia: unifying basic research and clinical aspects. This is a preview of subscription content, access via your institution. Schizophr Res 46: 175–186, Loughland CM, Williams LM, Gordon E (2002) Visual scanpaths to positive and negative facial emotions in an outpatient schizophrenia sample. Am J Med Genet 125B: 50–53, Mosher LR, Pollin W, Stabenau JR (1971) Identical twins discordant for schizophrenia. Prediction and patterns of change. Schizophr Res 9: 49–58, Heinrichs DW, Buchanan RW (1988) Significance and meaning of neurological signs in schizophrenia. Recent findings and their pathophysiological implications. : Praxis der … Auch im höheren Lebensalter gelten Neuroleptika bei einer Schizophrenie oder wahnhaften Störung als Medikamente erster Wahl. Eur Arch Psychiatry Clin Neurosci 246: 279–284, Williams J, Spurlock G, Holmans P et al (1998) A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia. Neuroimage 13: 433–446, Meyer-Lindenberg A, Poline JB, Kohn PD, Holt JL, Egan MF, Weinberger DR, Berman KF (2001) Evidence for abnormal cortical functional connectivity during working memory in schizophrenia. Am J Psychiatry 158: 1286–1290, Kovács I (2000) Human development of perceptual organization. Dr. rer. Schizophrenie ist eine Störung, die durch eine Veränderung des Denkens, der Wahrnehmung, des Verhaltens und der Affektivität gekennzeichnet ist. Psychiatry Res 120: 155–164, Gourion D, Goldberger C, Bourdel MC, Bayle FJ, Millet B, Olie JP, Krebs MO (2003) Neurological soft signs and minor physical anomalies in schizophrenia: differential transmission within families. Am J Psychiatry 159: 821–828, Wei J, Hemmings GP (2000) The NOTCH4 locus is associated with susceptibility to schizophrenia. Am J Med Genet 81: 282–289, Keller A, Castellanos FX, Vaituzis AC, Jeffries NO, Giedd JN, Rapoport JL (2003) Progressive loss of cerebellar volume in childhood-onset schizophrenia. Neurobiologie psychischer Störungen pp 345–386Cite as. Schizophr Bull 27: 457–476, Mathalon DH, Ford JM, Rosenbloom M, Pfefferbaum A (2000) P300 reduction and prolongation with illness duration in schizophrenia. Brain Res Bull 56: 413–424, Bailer U, Leisch F, Meszaros K et al (2000) Genome scan for susceptibility loci for schizophrenia. Biol Psychiatry 50: 729–749, Konradi C, Heckers S (2003) Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Hum Hered 54: 199–209, Buchanan RW, Heinrichs DW (1989) The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Ztsch Klin Psychol 24: 252–262, Rist F (1995) Psychologische Beiträge zum Verständnis schizophrener Störungen. Psychiatry Clin Neurosci 55: 611–618, Taylor SF, Liberzon I, Decker LR, Koeppe RA (2002) A functional anatomic study of emotion in schizophrenia. Ann NY Acad Sci 985: 445–460, Lezak MD (1995) Neuropsychological assessment, 3rd ed. Schizophr Bull 25: 201–222, Keil A, Junghöfer M, Saleptsi E, Streit M, Neuner F, Rockstroh B, Elbert T (2002) MEG parameters of affective processing in schizophrenia and posttraumatic stress disorder. Dev Psychopathol 12: 501–527, Marx CE, Lieberman JA (1998) Psychoneuroendocrinology of schizophrenia. Am Psychologist 48: 221–233, Heinrichs RW, Awad AG (1993) Neurocognitive subtypes of chronic schizophrenia. Barth, Leipzig, Lane A, Colgan K, Moynihan F, Burke T, Waddington JL, Larkin C, O’Callaghan E (1996) Schizophrenia and neurological soft signs: gender differences in clinical correlates and antecedent factors. I. Robustness of genetic marker investigative strategies. Am J Psychiatry 149: 255–257, Torrey EF (2002) Studies of individuals with schizophrenia never treated with antipsychotic medication: A review. Biol Psychiatry 44: 1081–1089, Ujike H, Takehisa Y, Takaki M et al (2001) NOTCH4 gene polymorphism and susceptibility to schizophrenia and schizoaffective disorder. 1] epidepride single photon emission tomography (SPET) study. Int J Psychophysiol 48: 1–10, Horley K, Gonsalvez C, Williams L, Lazzaro I, Bahmramali H, Gordon E (2001) Event-related potentials to threat-related faces in schizophrenia. PubMed  Tax calculation will be finalised during checkout. Schizophr Res 43: 109–116, Böning J, Drechsler F, Neuhauser B (1989) Somatosensory event-related potentials and selective attention impairment in young chronic schizophrenics. Brain Behav Immun 15: 319–339, Rothermundt M, Peters M, Prehn JHM, Arolt V (2003a) S100B in brain damage and neurodegeneration. Am J Psychiatry 160: 709–719, Canive JM, Lewine JD, Edgar JC, Davis JT, Miller GA, Torres F, Tuason VB (1998) Spontaneous brain magnetic activity in schizophrenic patients treated with aripiprazole. Arch Gen Psychiatry 59: 1011–1020, Elbert T, Lutzenberger W, Rockstroh B, Berg P, Cohen R (1992) Physical aspects of the EEG in schizophrenics. Initial validation. Schizophr Res 35: 263–278, Knott VJ, Labelle A, Jones B, Mahoney C (2002) EEG coherence following acute and chronic clozapine in treatment-resistant schizophrenics. Ann NY Acad Sci 917: 456–467, Mundt C, Lang H (1987) Die Psychopathologie der Schizophrenie. Can J Psychiatry 48: 338–341, PubMed  Die Änderungen umfassen den Verzicht auf die klassischen Subtypen … Ein Lehrbuch für Studierende und Ärzte, 7. Schizophr Bull 19: 551–556, Madsen AL, Vorstrup S, Rubin P, Larsen JK, Hemmingsen R (1999) Neurological abnormalities in schizophrenic patients: a prospective follow-up study 5 years after first admission. Es gibt gute Gründe für die Annahme, dass mehrere dieser neuen Gendefekte auch für verwandte Störungen wie Autismus, Schizophrenie oder Epilepsie verantwortlich sind. Google Scholar, Addington J, Brooks BL, Addington D (2003) Cognitive functioning in first episode psychosis: Initial presentation. Am J Psychiatry 160: 142–148, Ho BC, Andreasen NC, Noploulos P, Arndt S, Magnotta V, Flaum M (2003b) Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. NeuroImage 19: 751–763, Schröder J, Niethammer R, Geider FJ, Reitz C, Binkert M, Jauss M, Sauer H (1992) Neurological soft signs in schizophrenia. Neurosci Lett 293: 69–71, Keshavan MS, Anderson S, Pettegrew JW (1994) Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? Behav Brain Sci 14: 1–84, Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? WebIn allen Phasen, ob akut oder chronisch, ist Psychotherapie nachweislich wirksam und ratsam.Seit 2014 sind Schizophrenie und affektive psychotische Störungen deshalb auch eine Indikation für Psychothera-pie gemäß Psychotherapie-Richtlinie – ohne die früheren Einschränkungen. A population-based modeling study. Schizophrenie ist eine Störung, die durch eine Veränderung des Denkens, der Wahrnehmung, des Verhaltens und der Affektivität gekennzeichnet ist. J Abnorm Psychol 105: 663–667, Silverstein SM, Kovács I, Corry R, Valone C (2000) Perceptual organization, the disorganization syndrome, and context processing in chronic schizophrenia. WebBei Menschen, die Verwandte 1. Nervenarzt 68: 212–225, Stassen HH, Coppoloa R, Gottesman I, Torrey EF, Kuny S., Rickler KC, Hell D (1999) EEG differences in monozygotic twins discordant and concordant for schizophrenia. Br J Psychiatry 181: 271–275, Kapur S, Seeman P (2001) Does fast dissocation from the dopamine D2 receptor explain the action of atypical antipsychotics? Am J Psychiatry 159: 2000–2006, Cullen TJ, Walker MA, Parkinson N, Craven R, Crow TJ, Esiri MM, Harrison PJ (2003) A post mortem study of the mediodorsal nucleus of the thalamus in schizophrenia. © 2023 Springer Nature Switzerland AG. So können sowohl die so genannten älteren als auch die neueren Neuroleptika das Risiko für einen Schlaganfall erhöhen. Biol Psychiatry 53: 376–384, Bassett AS, Chow EW, O’Neill S, Brzustowicz LM (2001) Genetic insights into the neurodevelopmental hypothesis of schizophrenia. Brain 122: 593–624, Harrison PJ, Eastwood SL (2001) Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. In: Häfner H (Hrsg) Was ist Schizophrenie? Neuropsychopharmacology 27: 672–683, Bartzokis G, Nuechterlein KH, Lu PH, Gitlin M, Rogers S, Mintz J (2003) Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study. A lateralisation study. Eur Arch Psychiatry Clin Neurosci 246: 249–255, Aleman A, Hijman R, de Haan EHF, Kahn RS (1999) Memory impairment in schizophrenia: A meta-analysis. Acta Psychiatr Scand 100: 119–125, Maier W, Lichtermann D, Rietschel M, Held T, Falkai P, Wagner M, Schwab S (1999) Genetik schizophrener Störungen — Neuere Konzepte und Befunde.